|Day Low/High||128.14 / 130.77|
|52 Wk Low/High||94.59 / 127.53|
General Electric issued fresh 2019 earnings guidance Thursday that missed analysts' forecast, sending shares in the troubled industrial giant sharply lower in pre-market trading.
General Electric shares jumped higher Monday after analyst at Citigroup said the company's recent warning on industrial free cash flow might mean its 2019 outlook is a bit clearer, even as the bank trimmed its price target on the stock following last week's sharp sell-off.
With China reducing its GDP forecast and Europe's central bank growing cautious, markets turned lower this week.
WASHINGTON, March 8, 2019 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.
One of General Electric's biggest liabilities will be outlined on Thursday.
General Electric shares extended declines Wednesday, taking shares to a fresh one-month low, after CEO Larry Culp warned that free cash flow from the conglomerate's industrial division is likely to remain negative this year.
General Electric Larry Culp said Tuesday that free cash flow from the conglomerate's industrial division is likely to remain negative this year but insisted the troubled group would accelerate its ongoing restructuring plan.
Danaher is a terrific multi-year story in the portfolio and represents a perfect example of why you can count on strong leadership teams over the long run.
We raised our price targets on Danaher and Palo Alto Networks last week.
Markets end volatile week little changed in spite of failed North Korea summit, and congressional testimony from Powell, Lighthizer and Cohen.
WASHINGTON, March 1, 2019 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher") announced today that it has closed concurrent offerings of 12,100,000 shares of common stock at a price to the public of $123.
The health insurance stocks are taking a hit today, but we're not sellers on Wednesday's news.
General Electric shares traded higher Wednesday after CEO Larry Culp told investors he was focused on reducing the conglomerate's debt load and boosting its dividend to a level "in line with our peers."
General Electric's move to sell the biopharma portion of its healthcare business to Danaher likely gives the company and extra $3 billion it can use to reduce its balance sheet, but will also cut into overall earnings in an already weakened company, according to one of Wall Street's top analysts.
WASHINGTON, Feb. 26, 2019 /PRNewswire/ -- Danaher Corporation (NYSE:DHR) ("Danaher") announced today that it has priced concurrent offerings of 11,000,000 shares of common stock at a price to the public of $123.
We've been slowly scaling out of this name, selling shares on its gradual climb higher because of valuation reasons.
Jim Cramer asks whether there aren't enough good things happening that we can sustain an advance without a China deal.
WASHINGTON, Feb. 25, 2019 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher") announced today that it has commenced concurrent offerings of $1.
The Dow Jones Industrial Average rose modestly Monday after Donald Trump said he will delay increasing tariffs on China-made goods.
If we can advance without China then who the heck knows where we can go with it.
Both Danaher and General Electric stocks are flying higher after the latter agreed to sell its biopharma unit to the latter for $23.4 billion.
A trade deal with China would be meaningful for any company that does a solid amount of business in the region, and perhaps more so the stocks tied to global economic growth.
Just because the stock is still down substantially from its all-time highs doesn't mean that it is still 'cheap'.
Jim breaks down the huge Danaher-GE deal, discusses what to make of CVS after last week's earnings report, talks about what a trade deal could mean for the broader market, and more!
Here's why Jim Cramer was pleased that General Electric sold its biopharma business to Danaher and what it means for Larry Culp's leadership.
General Electric agreesd to sell the biopharma portion of its life sciences business to Danaher, the firm that GE CEO Larry Culp ran for around 13 years, for $21.4 billion in cash.
Jim Cramer has an acquisition idea for Berkshire Hathaway and his reaction to GE's sale of its biopharma sale.
The question for us though becomes is this, or when is, the right time for investors to create some value for themselves?
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.